Drug Shortage Report for XERESE

Last updated on 2020-03-05 History
Report ID 102991
Drug Identification Number 02404044
Brand name XERESE
Common or Proper name XERESE
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR HYDROCORTISONE
Strength(s) 5% 1%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size n/a
ATC code D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-06
Estimated end date
Actual end date 2020-03-02
Shortage status Resolved
Updated date 2020-03-05
Company comments waiting QA release
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-01-09 English Compare
v2 2020-01-09 French Compare
v3 2020-01-23 English Compare
v4 2020-01-23 French Compare
v5 2020-02-14 English Compare
v6 2020-02-14 English Compare
v7 2020-02-14 French Compare
v8 2020-03-05 English Compare
v9 2020-03-05 French Compare